Medical Device User Fees; Public Meeting; Extension of Comment Period, 63845 [2010-26253]

Download as PDF Federal Register / Vol. 75, No. 200 / Monday, October 18, 2010 / Notices infection control in ambulatory care settings. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Michelle King, HICPAC, Division of Healthcare Quality Promotion, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333. Telephone (404) 639–2936. E-mail: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 8, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–26113 Filed 10–15–10; 8:45 am] Name of Committee: National Institute of Mental Health Special Emphasis Panel; Services Conflicts. Date: November 12, 2010. Time: 11 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Aileen Schulte, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–1225, aschulte@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: October 8, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–26161 Filed 10–15–10; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSKH9S0YB1PROD with NOTICES National Institute of Mental Health; Notice of Closed Meetings Food and Drug Administration Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITVA Conflicts & Eating Disorders. Date: November 10, 2010. Time: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Francois Boller, MD, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MSC 9606, Bethesda, MD 20892–9606, 301–443–1513, bollerf@mail.nih.gov. VerDate Mar<15>2010 16:45 Oct 15, 2010 Jkt 223001 [Docket No. FDA–2010–N–0389] Medical Device User Fees; Public Meeting; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. The Food and Drug Administration (FDA) is extending to November 1, 2010, the comment period for the notice that appeared in the Federal Register of August 13, 2010 (75 FR 49502). In the notice, FDA requested input and comments from interested stakeholders on the Agency’s medical user fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program. The Agency is taking this action to allow interested persons additional time to submit comments. SUMMARY: Submit either electronic or written comments and information by November 1, 2010. ADDRESSES: Submit electronic comments to https:// www.regulations.gov. Submit written comments to the Division of Dockets DATES: PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 63845 Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. To ensure consideration, all comments must be received by November 1, 2010. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993–0002, 301–796–6313, FAX: 301–847–8121, e-mail: James.Swink@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of August 13, 2010 (75 FR 49502), FDA published a notice announcing a public meeting on September 14, 2010, and the opening of a public docket to seek input and comments from interested stakeholders to discuss the Agency’s medical user fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program. Interested persons were invited to submit comments to the public docket by October 14, 2010. At this time, the Agency is announcing its intention to post the transcript of the September 14, 2010, public meeting and is extending the comment period until November 1, 2010, to continue to receive public comments. II. Request for Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments regarding this document. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: October 14, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–26253 Filed 10–14–10; 4:15 pm] BILLING CODE 4160–01–P E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 75, Number 200 (Monday, October 18, 2010)]
[Notices]
[Page 63845]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26253]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0389]


Medical Device User Fees; Public Meeting; Extension of Comment 
Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending to 
November 1, 2010, the comment period for the notice that appeared in 
the Federal Register of August 13, 2010 (75 FR 49502). In the notice, 
FDA requested input and comments from interested stakeholders on the 
Agency's medical user fee program and requested suggestions regarding 
the commitments FDA should propose for the next reauthorized program. 
The Agency is taking this action to allow interested persons additional 
time to submit comments.

DATES: Submit either electronic or written comments and information by 
November 1, 2010.

ADDRESSES: Submit electronic comments to https://www.regulations.gov. 
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852. To ensure consideration, all comments must be 
received by November 1, 2010. Identify comments with the docket number 
found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993-0002, 301-796-6313, 
FAX: 301-847-8121, e-mail: James.Swink@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of August 13, 2010 (75 FR 49502), FDA 
published a notice announcing a public meeting on September 14, 2010, 
and the opening of a public docket to seek input and comments from 
interested stakeholders to discuss the Agency's medical user fee 
program and requested suggestions regarding the commitments FDA should 
propose for the next reauthorized program. Interested persons were 
invited to submit comments to the public docket by October 14, 2010. At 
this time, the Agency is announcing its intention to post the 
transcript of the September 14, 2010, public meeting and is extending 
the comment period until November 1, 2010, to continue to receive 
public comments.

II. Request for Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments regarding this 
document. It is only necessary to send one set of comments. It is no 
longer necessary to send two copies of mailed comments. Identify 
comments with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: October 14, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-26253 Filed 10-14-10; 4:15 pm]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.